An effort to replicate dozens of
cancer biology studies that were widely cited (bold numbers) has reported its first results: two confirmations, one failure, and two that were inconclusive because of technical problems.
On ScienceInsider, Jennifer Couzin - Frankel reports that the Reproducibility Initiative has received a $ 1.3 million grant from the Laura and John Arnold Foundation to fund the independent validation of 50 important
cancer biology studies published between 2010 and 2012.
Not exact matches
In an accompanying editorial, Theodore Slotkin, a professor of pharmacology and
cancer biology at the Duke University School of Medicine in Durham, North Carolina, writes that it's undeniable that smoking while pregnant contributes to later behavior problems in children, based on the new
study and past research.
His work focuses on applying principles of evolutionary
biology and ecology to the
study of
cancer.
The results, though not surprising, offer a reminder that, with so many people vying for so few tenure - track faculty positions, «trainees need to do more self - analysis of where they are and what the realities are for them to potentially become a faculty member,» says
study author Nathan Vanderford, an assistant professor of toxicology and
cancer biology and assistant dean for academic development at the University of Kentucky in Lexington.
Our
study demonstrates, conversely, that a binary designation of resistance may oversimplify
cancer's true
biology.
The process of integrating naturally occurring
cancers in dogs into the general
studies of human
cancer biology and therapy is known as comparative oncology.
Commenting on the results for ESMO, Dr Evandro de Azambuja, Head of the Medical Support Team, Academic Promoting Team, Jules Bordet Institute, Brussels, Belgium, said: «This
study shows that it's not only tumour size that is important for breast
cancer patients but also tumour
biology.
GIS's DNA analysistechnique has allowed the researchers to further
study the
biology of Opisthorchis viverrini to understand the cause and the eventual development of treatments for bile duct
cancer, a condition caused by the parasite.
Co-author Dr. David Hinds from 23andMe said: «While the genetics of hair colour is an interesting problem in itself, we hope that better understanding of the
biology of melanin pigmentation will be applicable to
studies of diseases that interact with pigmentation, such as skin
cancer or vitiligo.»
Ana Soto, professor of cellular
biology at Tufts University School of Medicine, and her colleagues were
studying the effects of estrogen on a breast
cancer cell line.
The
study, «VlincRNAs controlled by retroviral elements are a hallmark of pluripotency and
cancer» found that novel non-coding parts of the human genome known as vlincRNAs (very long intergenic, non-coding RNAs) triggered by ancient viruses, participate in the
biology of stem cells, and in the development of
cancer.
The St. Laurent Institute, a non-profit medical research institute focused on the systems
biology of disease, today announced in a
study published in the July edition of Genome
Biology, that genetic matter, previously ignored by the scientific community, may play an important role in
cancer.
A novel Yale
study answers age - old questions about how
cancers spread by applying tools from evolutionary
biology.
«Forty years ago, very little was known about breast
cancer disease
biology — such as subtypes, differences in radio - sensitivities, radio - resistances, local recurrence and in metastatic potential,» explains Bedrosian, the
study's senior author.
He subsequently obtained a Ph.D. at the University of Sydney
studying cancer cell biology, and was awarded a Fulbright Fellowship to undertake postdoctoral research at the National Cancer Institute, National Institutes of Health in Bethesda, Mar
cancer cell
biology, and was awarded a Fulbright Fellowship to undertake postdoctoral research at the National
Cancer Institute, National Institutes of Health in Bethesda, Mar
Cancer Institute, National Institutes of Health in Bethesda, Maryland.
«This
study opens an entirely new area of discovery for many aspects of cell
biology and biomedical research — how
cancer cells metastasize, for example — and provides many new therapeutic targets,» said senior author Jack Dixon, PhD, professor in the UC San Diego School of Medicine and associate vice chancellor of Scientific Affairs.
Areas covered range from basic
studies into the
biology of innate and adaptive immunity (immune cell development and differentiation, immunogenomics, systems immunology, structural immunology, antigen presentation, immunometabolism, and mucosal immunology) to immune contributions to health and disease (host defense, inflammation,
cancer immunology, autoimmunity, allergy, transplantation, and immunodeficiency).
Jason Sheltzer, the article's first author, is a graduate student,
studying cancer biology at the Massachusetts Institute of Technology (MIT) in Cambridge.
The
study's conclusions address a major challenge in current standards of care for prostate
cancer: Without knowing a tumor's underlying
biology, physicians can not reliably predict which of their patients will develop dangerous forms of the disease.
Mathew Garnett, a
cancer biologist at the Wellcome Trust Sanger Institute near Cambridge, UK, says that HeLa cells could prove useful for
studying aspects of the
biology of cervical tumors, such as their response to
cancer drugs.
With VEGF - A and CEA, we believe we may have invented a test that can help that group of patients who don't have a risk of
cancer get off the testing cycle and avoid surgery which, in and of itself, has a risk of mortality or complications,» said C. Max Schmidt, MD, PhD, FACS,
study author and professor of surgery and biochemical / molecular
biology, Indiana University School of Medicine.
The
study was published in the December issue of Experimental Hematology, the official publication of the Society for Hematology and Stem Cells, and also highlighted in the journal's editorial due to its significance in the
biology and treatment of blood
cancer.
Development, oversight, and teaching were coordinated by Kim Petrie, assistant professor of medical education and administration, Rob Carnahan, director of the Antibody and Protein Resource core facility and associate professor of
cancer biology, and Joe Rando, associate professor of managerial
studies.
The piece was on the
biology of lung
cancer, which I had written during my
studies.
The SFU molecular
biology and biochemistry professor is this
study's senior author, and the associate director and head of bioinformatics at the B.C.
Cancer Agency's Genome Sciences Centre.
The
study was led by Guoping Fan, professor of human genetics and molecular
biology and member of both the Jonsson Comprehensive
Cancer Center and the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research.
«Scientists have learned a lot about development, gene regulation, and
cancer biology, among other things, by
studying C. elegans.
«In addition to having a higher prevalence of triple - negative breast
cancers than Caucasian women — something that has been documented in previous
studies — we found that African American women with breast
cancer had a significantly higher prevalence of the TP53 driver mutation, basal tumor subtype and greater genomic diversity within tumors, all of which suggest more aggressive tumor biology,» says Tanya Keenan, MD, of the MGH Cancer Center, lead author of the
cancer had a significantly higher prevalence of the TP53 driver mutation, basal tumor subtype and greater genomic diversity within tumors, all of which suggest more aggressive tumor
biology,» says Tanya Keenan, MD, of the MGH
Cancer Center, lead author of the
Cancer Center, lead author of the
study.
«New insights into the
biology of heart failure are desperately needed to prompt new types of targeted therapeutic agents,» says senior
study author James Bradner of the Dana - Farber
Cancer Institute and Harvard Medical School.
Amanda Curtis drew up a life plan in college that included
studying biology in preparation for «spending time in the lab, working on a cure for
cancer.»
Dr Toral Gathani, a clinical epidemiologist at the University of Oxford [1], told the 10th European Breast
Cancer Conference (EBCC - 10) today (Thursday) that findings from the largest
study to date of tumour characteristics in relation to ethnicity suggested that inherent differences in tumour
biology between the ethnic groups were unlikely to play a role.
There is really no reliable method for recapitulating the metastatic progression from a primary tumor in the colon to the liver,» says Omer Yilmaz, an MIT assistant professor of
biology, a member of MIT's Koch Institute for Integrative
Cancer Research, and the lead senior author of the
study, which appears in the May 1 issue of Nature Biotechnology.
«Liver
cancer is on the rise worldwide, and in human
studies we've now seen that patients can progress from fatty liver disease to liver
cancer without any middle steps such as cirrhosis,» says David Moore, a professor of molecular and cellular
biology, who led the
study with Associate Professor Loning Fu, both at Baylor.
Of note, the current
study is part of a recent surge in NYU Langone findings on pancreatic
cancer, including
studies on how first - responder cells turn off the immune response, the role of the drug nab - paclitaxel in tumor
biology,
cancer cells» unique fuel sources, and how immune cell infighting drives the disease.
Dr Luca Peruzzotti - Jametti, the first author of the
study and a Wellcome Trust Research Training Fellow, says: «We made this discovery by bringing together researchers from diverse fields including regenerative medicine,
cancer, mitochondrial
biology, inflammation and stroke and cellular reprogramming.
For example, Patricia Keely, professor and chair of cell and regenerative
biology who
studies the matrix surrounding cells, is exploring its link to breast
cancer.
They are a couple: Jason Sheltzer, a graduate student
studying cancer biology at the Massachusetts Institute of Technology (MIT) in Cambridge, and Joan C. Smith, a software engineer in Twitter's Cambridge office.
On Capitol Hill last week, Weinberg, an expert in the molecular
biology of
cancer, pointed out to the Congressional Biomedical Research Caucus that the major advances in understanding human
cancer genetics had come, not from
studying breast tissue, but from
studying cow warts, worm vulvas, fruitfly retinas, and a chicken virus.
Focused both on discovery and on mentoring future generations of researchers, Salk scientists make groundbreaking contributions to our understanding of
cancer, aging, Alzheimer's, diabetes and infectious diseases by
studying neuroscience, genetics, cell and plant
biology and related disciplines.
The
cancer biology project was inspired by reports from two companies that when they tried to follow up on dozens of papers pointing to potential new drugs, they could not replicate as many as 89 % of the
studies.
The aim of the Interdisciplinary Training in
Cancer Research training program is to train young scientists to design and conduct research on significant problems in cancer by combining information and approaches from different scientific disciplines, including basic cellular and molecular biology, epidemiology, clinical trials and studies, and behavioral - social sci
Cancer Research training program is to train young scientists to design and conduct research on significant problems in
cancer by combining information and approaches from different scientific disciplines, including basic cellular and molecular biology, epidemiology, clinical trials and studies, and behavioral - social sci
cancer by combining information and approaches from different scientific disciplines, including basic cellular and molecular
biology, epidemiology, clinical trials and
studies, and behavioral - social sciences.
«It's probably the single most common gene fusion in human
cancer,» said study co-leader Antonio Iavarone, MD, professor of neurology and of pathology and cell biology (in the Institute for Cancer Genetics) at
cancer,» said
study co-leader Antonio Iavarone, MD, professor of neurology and of pathology and cell
biology (in the Institute for
Cancer Genetics) at
Cancer Genetics) at CUMC.
NEW YORK and SEATTLE — April 5, 2018 — The
Cancer Research Institute (CRI), Institute for Systems Biology (ISB) and Sage Bionetworks — three organizations on the forefront of cancer immunotherapy, systems biology and bioinformatics — today announced the release of the Cancer Research Institute iAtlas, a comprehensive web - based tool that allows oncologists and researchers to study and analyze interactions between tumors and the immune microenviro
Cancer Research Institute (CRI), Institute for Systems
Biology (ISB) and Sage Bionetworks — three organizations on the forefront of
cancer immunotherapy, systems biology and bioinformatics — today announced the release of the Cancer Research Institute iAtlas, a comprehensive web - based tool that allows oncologists and researchers to study and analyze interactions between tumors and the immune microenviro
cancer immunotherapy, systems
biology and bioinformatics — today announced the release of the
Cancer Research Institute iAtlas, a comprehensive web - based tool that allows oncologists and researchers to study and analyze interactions between tumors and the immune microenviro
Cancer Research Institute iAtlas, a comprehensive web - based tool that allows oncologists and researchers to
study and analyze interactions between tumors and the immune microenvironment.
Studying rare familial syndromes can have broad implications to our understanding of
cancer biology.
The purpose of the Core for Biomolecular Structure and Function (CBSF) is to provide recombinant protein production, protein characterization, binding
studies and structural
biology (X-ray crystallography) services to MD Anderson
Cancer Center and the wider Texas Medical Center.
And
cancer research now involves collaborative efforts from researchers in disciplines such as physics, advanced mathematics, structural
biology, nanotechnology, and many more, who have introduced new concepts and approaches to
studying cancer.
This census, published in Nature, comprises a first - draft atlas of the small intestine's cellular composition, providing a reference for
studying the
biology of a host of conditions affecting or involving the gut, such as inflammatory bowel disease,
cancers of the small intestine, celiac disease, and food allergies.
For understanding the
biology of gene - gene, gene - drug and gene - microenvironment interactions, a considerably broader range of in vitro and in vivo model systems is required — we are generating 1,000 organoid cultures from human
cancers, characterising their genomes, functional dependencies and drug response, and we are expanding our in vivo models to
study the interface between
cancer and the immune system and microenvironment.
We use various approaches including genetics, genomics and cell
biology to
study gene functions in normal development and disease such as
cancer.